|
|
Volumn 50, Issue 5, 1995, Pages 497-504
|
|
Subsensitivity of bronchodilator and systemic β2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients
a
|
|
Author keywords
12 adrenoceptor; Asthma; Bronchodilator subsensitivity; Eformoterol
|
|
Indexed keywords
BETA 2 ADRENERGIC RECEPTOR;
CORTICOSTEROID;
IPRATROPIUM BROMIDE;
PLACEBO;
ADULT;
ARTICLE;
ASTHMA;
BRONCHODILATATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG SENSITIVITY;
DRUG TOLERANCE;
DRY DEPOSITION;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
LYMPHOCYTE;
MALE;
PEAK EXPIRATORY FLOW;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ADOLESCENT;
ADRENERGIC BETA-AGONISTS;
ADULT;
AEROSOLS;
ASTHMA;
BRONCHI;
BRONCHODILATOR AGENTS;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
DRUG TOLERANCE;
ETHANOLAMINES;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PEAK EXPIRATORY FLOW RATE;
RECEPTORS, ADRENERGIC, ALPHA-2;
SENSITIVITY AND SPECIFICITY;
|
|
EID: 0029036653
PISSN: 00406376
EISSN: None
Source Type: Journal
DOI: 10.1136/thx.50.5.497 Document Type: Article |
|
Times cited : (115)
|
|
References (0)
|
